stockrow
Friday 6 November 2026
Export BKD’s income statement to Excel — free account
Brookdale Senior Living Inc.
BKD Healthcare Medical Care Facilities
Brookdale Senior Living Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.2 billion, up 2.19% from fiscal 2024.
- Revenue
- −11.6%
- EPS
- +155.6%
- Free cash flow
- +533.1%
- Total debt
- +0.07%
Quarter to June 2026, against a year earlier
10.89
0.30
−2.68%
Follow BKD
Alert me
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
0.62 | 0.79 | 1.04 | 1.26 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
26.29 | 73.47 | 155.95 | 41.86 | |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
1.86 | 2.05 | 2.32 | 2.54 | |
EV/EBITDA |
16.03 | 17.05 | 18.77 | 17.75 | |
EV/Operating CF |
26.25 | 30.01 | 33.81 | 34.59 | |
EV/FCF |
(88.42) | (22.21) | (24.15) | (54.93) | |
Quick Ratio |
0.57 | 0.67 | 0.68 | 0.92 | |
Current Ratio |
0.84 | 0.98 | 1.03 | 1.14 | |
Net Debt/EBITDA |
89.31 | 38.71 | 31.31 | 24.45 | |
Debt/Assets |
71.31% | 72.52% | 73.44% | 73.19% | |
Debt/Equity |
(802.69) | (99.52) | (79.37) | (156.38) | |
Asset Turnover |
0.54 | 0.52 | 0.52 | 0.51 | |
Operating CF/Net income |
(0.67) | (0.86) | (3.03) | 3.95 | |
Capex/Depreciation |
(0.43) | (4.65) | (0.60) | 1.34 | |
Interest Coverage |
(0.87) | 0.38 | 0.90 | 1.51 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
6.26% | 5.49% | 5.89% | 6.56% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.32% | 0.30% | 0.48% | 0.52% | |
Graham Net Nets |
(2.72) | (2.14) | (1.66) | (1.39) | |
Graham Number |
0.81 | 2.15 | 2.11 | 1.23 | |
Earnings Yield |
(15.47%) | (10.29%) | (6.29%) | (3.60%) | |
Free Cash Flow Yield |
(3.38%) | (11.61%) | (9.26%) | (3.66%) | |
Revenue per Share |
3.42 | 3.21 | 3.21 | 3.00 | |
Operating CF per Share |
0.32 | 0.15 | 0.09 | 0.38 | |
Capex per Share |
(0.18) | (1.59) | (0.20) | 0.41 | |
Free Cash Flow per Share |
0.14 | (1.45) | (0.11) | 0.80 | |
Cash per Share |
1.24 | 1.33 | 1.27 | 1.77 | |
Shareholders Equity per Share |
(0.02) | (0.18) | (0.23) | (0.12) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(0.02) | (0.18) | (0.23) | (0.12) | |
Free Cash Flow |
33.89 | (340.14) | (25.59) | 190.86 | |
Working Capital |
(100.83) | (13.98) | 17.98 | 74.61 | |
Capital Expenditures |
(42.64) | (374.68) | (46.48) | 98.94 | |
Net Current Asset Value |
(5,481.11) | (5,441.68) | (5,399.83) | (5,332.33) | |
EV/EBIT |
0.00 | 484.68 | 204.13 | 73.02 | |
Capex to Sales |
0.05 | 0.50 | 0.06 | (0.14) | |
Price to Operating Income |
0.00 | 188.00 | 91.25 | 36.29 | |
| Other line items | |||||
Average Receivables |
60.28 | 59.79 | 61.13 | 56.25 | |
Average Payables |
79.02 | 70.31 | 78.75 | 83.45 | |
Average Assets |
5,975.92 | 6,143.90 | 6,051.75 | 6,021.64 | |
Average Common Equity |
144.49 | 85.26 | 46.78 | 39.58 |
Columns are period end dates